Modafinil acid: Difference between revisions
No edit summary |
No edit summary |
||
Line 32: | Line 32: | ||
}} |
}} |
||
'''Modafinil acid''' (code name '''CRL-40467'''), also known as '''modafinilic acid''' or '''modafinil carboxylate''', is one of the two major |
'''Modafinil acid''' (code name '''CRL-40467'''), also known as '''modafinilic acid''' or '''modafinil carboxylate''', is the major metabolite of [[modafinil]], and one of the two major metabolites of modafinil – the other being [[modafinil sulfone]]. Modafinil acid is also a metabolite of the modafinil [[prodrug]], [[adrafinil]], and the (R)-[[enantiomer]] is a metabolite of [[armodafinil]], the (R)-enantiomer of modafinil. Modafinil acid seems to be inactive,<ref name="WongWang1998">{{cite journal|last1=Wong|first1=Y. Nancy|last2=Wang|first2=Lixia|last3=Hartman|first3=Linda|last4=Simcoe|first4=Donna|last5=Chen|first5=Yusong|last6=Laughton|first6=Watson|last7=Eldon|first7=Richard|last8=Markland|first8=Colin|last9=Grebow|first9=Peter|title=Comparison of the Single-Dose Pharmacokinetics and Tolerability of Modafinil and Dextroamphetamine Administered Alone or in Combination in Healthy Male Volunteers|journal=The Journal of Clinical Pharmacology|volume=38|issue=10|year=1998|pages=971–978|issn=00912700|doi=10.1002/j.1552-4604.1998.tb04395.x}}</ref> and does not appear to contribute to the [[wakefulness-promoting agent|wakefulness-promoting]]/[[psychostimulant]] effects of modafinil.<ref name="SchwertnerKong2005">{{cite journal|last1=Schwertner|first1=Harvey A.|last2=Kong|first2=Suk Bin|title=Determination of modafinil in plasma and urine by reversed phase high-performance liquid-chromatography|journal=Journal of Pharmaceutical and Biomedical Analysis|volume=37|issue=3|year=2005|pages=475–479|issn=07317085|doi=10.1016/j.jpba.2004.11.014}}</ref><ref name="RobertsonHellriegel2003">{{cite journal|last1=Robertson|first1=Philmore|last2=Hellriegel|first2=Edward T.|title=Clinical Pharmacokinetic Profile of Modafinil|journal=Clinical Pharmacokinetics|volume=42|issue=2|year=2003|pages=123–137|issn=0312-5963|doi=10.2165/00003088-200342020-00002}}</ref><ref name="Robertson2002">{{cite journal|last1=Robertson|first1=P|title=Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers|journal=Clinical Pharmacology & Therapeutics|volume=71|issue=1|year=2002|pages=46–56|issn=00099236|doi=10.1067/mcp.2002.121217}}</ref> |
||
In the [[catabolism|breakdown]] process of modafinil, modafinil is primarily [[hydrolysis|hydrolyzed]] by an [[esterase]] or [[amidase]] [[enzyme]] into modafinil acid.<ref name="WuGuo2012">{{cite journal|last1=Wu|first1=Ke-hua|last2=Guo|first2=Tao|last3=Deng|first3=Chen-hui|last4=Guan|first4=Zheng|last5=Li|first5=Liang|last6=Zhou|first6=Tian-yan|last7=Lu|first7=Wei|title=Population pharmacokinetics of modafinil acid and estimation of the metabolic conversion of modafinil into modafinil acid in 5 major ethnic groups of China|journal=Acta Pharmacologica Sinica|volume=33|issue=11|year=2012|pages=1401–1408|issn=1671-4083|doi=10.1038/aps.2012.124}}</ref> The apparent [[clearance (medicine)|clearance]] of modafinil acid is significantly higher than that of modafinil, following the hypothesis that metabolism increases the [[polarity]] and the clearance of modafinil. |
In the [[catabolism|breakdown]] process of modafinil, modafinil is primarily [[hydrolysis|hydrolyzed]] by an [[esterase]] or [[amidase]] [[enzyme]] into modafinil acid.<ref name="WuGuo2012">{{cite journal|last1=Wu|first1=Ke-hua|last2=Guo|first2=Tao|last3=Deng|first3=Chen-hui|last4=Guan|first4=Zheng|last5=Li|first5=Liang|last6=Zhou|first6=Tian-yan|last7=Lu|first7=Wei|title=Population pharmacokinetics of modafinil acid and estimation of the metabolic conversion of modafinil into modafinil acid in 5 major ethnic groups of China|journal=Acta Pharmacologica Sinica|volume=33|issue=11|year=2012|pages=1401–1408|issn=1671-4083|doi=10.1038/aps.2012.124}}</ref> The apparent [[clearance (medicine)|clearance]] of modafinil acid is significantly higher than that of modafinil, following the hypothesis that metabolism increases the [[polarity]] and the clearance of modafinil. |
Revision as of 20:14, 26 January 2016
Names | |
---|---|
IUPAC name
2-Benzhydrylsulfinylacetic acid
| |
Other names
Modafinilic acid; Modafinil carboxylate; CRL-40467
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.219.633 |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C15H14O3S | |
Molar mass | 274.33 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Modafinil acid (code name CRL-40467), also known as modafinilic acid or modafinil carboxylate, is the major metabolite of modafinil, and one of the two major metabolites of modafinil – the other being modafinil sulfone. Modafinil acid is also a metabolite of the modafinil prodrug, adrafinil, and the (R)-enantiomer is a metabolite of armodafinil, the (R)-enantiomer of modafinil. Modafinil acid seems to be inactive,[1] and does not appear to contribute to the wakefulness-promoting/psychostimulant effects of modafinil.[2][3][4]
In the breakdown process of modafinil, modafinil is primarily hydrolyzed by an esterase or amidase enzyme into modafinil acid.[5] The apparent clearance of modafinil acid is significantly higher than that of modafinil, following the hypothesis that metabolism increases the polarity and the clearance of modafinil.
References
- ^ Wong, Y. Nancy; Wang, Lixia; Hartman, Linda; Simcoe, Donna; Chen, Yusong; Laughton, Watson; Eldon, Richard; Markland, Colin; Grebow, Peter (1998). "Comparison of the Single-Dose Pharmacokinetics and Tolerability of Modafinil and Dextroamphetamine Administered Alone or in Combination in Healthy Male Volunteers". The Journal of Clinical Pharmacology. 38 (10): 971–978. doi:10.1002/j.1552-4604.1998.tb04395.x. ISSN 0091-2700.
- ^ Schwertner, Harvey A.; Kong, Suk Bin (2005). "Determination of modafinil in plasma and urine by reversed phase high-performance liquid-chromatography". Journal of Pharmaceutical and Biomedical Analysis. 37 (3): 475–479. doi:10.1016/j.jpba.2004.11.014. ISSN 0731-7085.
- ^ Robertson, Philmore; Hellriegel, Edward T. (2003). "Clinical Pharmacokinetic Profile of Modafinil". Clinical Pharmacokinetics. 42 (2): 123–137. doi:10.2165/00003088-200342020-00002. ISSN 0312-5963.
- ^ Robertson, P (2002). "Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers". Clinical Pharmacology & Therapeutics. 71 (1): 46–56. doi:10.1067/mcp.2002.121217. ISSN 0009-9236.
- ^ Wu, Ke-hua; Guo, Tao; Deng, Chen-hui; Guan, Zheng; Li, Liang; Zhou, Tian-yan; Lu, Wei (2012). "Population pharmacokinetics of modafinil acid and estimation of the metabolic conversion of modafinil into modafinil acid in 5 major ethnic groups of China". Acta Pharmacologica Sinica. 33 (11): 1401–1408. doi:10.1038/aps.2012.124. ISSN 1671-4083.